The "New Vice" Economy: 5 Stocks Profiting from the Shift to Clean Fuel

Executive Summary

• The release highlights a broad consumer shift toward functional wellness products, positioning several companies—including Doseology Sciences, Philip Morris International, Canopy Growth, Zevia, and Lifeway Foods—to benefit from this trend.
• Doseology announced a strategic manufacturing agreement, an advisory partnership with Joseph Mimran, and the acquisition of Feed That Brain for $400k in securities.
• Zevia reported Q3‑2025 financial results (net sales $40.8 M, 12.3% YoY growth) but posted a net loss of $2.8 M; cash balance stood at ~$26.0 M with no debt.

Key Details

• Consumer Trend Data
• Over 46 million consumer mentions tracked for wellness products.

• Younger adults (36 % of adult population) generate 41 % of wellness spending.

• Doseology Sciences Inc.

• Launched Investor Communications Initiative in early Dec 2025 to improve disclosure and capital‑market readiness.
• Secured a strategic manufacturing agreement with its wholly‑owned subsidiary Doseology USA Inc. (Florida) to begin commercial production of caffeine, nicotine, and functional ingredient pouches.
• Head of Commercialization: Patrick Sills (formerly joint venture manager for Swedish Match & Philip Morris).

• Acquired Feed That Brain (Toronto health‑supplements brand) for $400,000 in securities; added strategic advisor Joseph Mimran under a three‑year advisory agreement valued at $400,000 in restricted share units.

• Philip Morris International

• Expanded partnership with Scuderia Ferrari HP & Ferrari Challenge Trofeo Pirelli for the 2026 season and beyond, featuring ZYN nicotine‑pouch branding on select Formula 1 liveries (first appearance at Abu Dhabi Grand Prix 2025).

• Smoke‑free products accounted for 41 % of total net revenues in the first nine months of 2025 (up from 25 % YoY).

• Canopy Growth Corporation

• Launched “Claybourne Gassers” – three 0.95 g liquid‑diamond vapes (92‑98 % THC) with digital display, variable voltage, anti‑burn/clog tech, USB‑C rechargeable format.

• Introduced “Frosted Flyers” 8‑pack (8 × 0.35 g) featuring strains with 33‑36 % THC; available in select Canadian retail and online stores.

• Zevia PBC

• Q3 2025 net sales: $40.8 M (+12.3 % YoY).
• Volume growth: 12.6 % YoY.
• Gross profit margin: 45.6 %, down 3.5 percentage points YoY (higher inventory losses & tariff impacts).
• Net loss: $2.8 M (including $0.9 M non‑cash equity compensation). Adjusted EBITDA loss: $1.7 M.

• Cash, cash equivalents & marketable securities at Sep 30 2025: ≈ $26.0 M; no debt; unused credit line of $20 M.

• Lifeway Foods

• Named to Inc.’s 2025 “Best Challenger Brands” list and recognized as a TIME Growth Leader and Dairy Foods’ Processor of the Year 2025.
• Products now sold across U.S., Mexico, Ireland, South Africa, UAE, and France.

Notable Quotes

• Chris Jackson, CEO, Doseology Sciences: “Our strategy is clear: to lead innovation in the oral stimulant category with a sharp focus on speed to market and operational excellence.”
• Stefano Volpetti, President Smoke‑Free Products & Chief Consumer Officer, PMI: “By engaging in this space, we demonstrate our commitment on this journey.”
• Amy Taylor, CEO, Zevia: “Our strong performance… underscores our continued progress across our strategic growth pillars.”
• Julie Smolyansky, CEO, Lifeway Foods: “Being recognized by Inc. is an incredible validation of our team's commitment to innovation and impact.”